Vistagen Therapeutics, Inc. (VTGN) › EPS (Diluted)Vistagen Therapeutics, Inc. (VTGN) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2011: $-1.812012: $-0.832013: $-1.272014: $-3.812015: $-10.612016: $-29.082023: $-8.512024: $-1.522025: $-1.672026: $-1.83$-1.832011EPS (Diluted) (USD/shares)2026Fiscal YearEPS (Diluted)Change YoY2026$-1.83-9.6%2025$-1.67-9.9%2024$-1.52+82.1%2023$-8.51—2016$-29.08-174.1%2015$-10.61-178.5%2014$-3.81-200.0%2013$-1.27-53.0%2012$-0.83+54.1%2011$-1.81—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share